紫堇灵代谢与生物活化:谷胱甘肽/半胱氨酸结合物表征及小鼠肝毒性评价
紫堇灵(CRL)是地丁草主要异喹啉生物碱。研究用高分辨质谱及三重四极杆质谱研究其代谢,在大鼠和人肝微粒体中发现3种代谢物和4种谷胱甘肽结合物,小鼠中另捕获4种半胱氨酸结合物;CYP3A4、CYP2C19、CYP2C9和CYP2D6主要参与其生物活化。实验剂量125-500 mg/kg下未见明显肝毒性,但小鼠出现行为异常和低体温,3只死亡;组织分布显示主要靶器官为肝,其次肾、心、脑,且可透过血脑屏障。
要点
- 紫堇灵经CYP3A4、CYP2C19、CYP2C9和CYP2D6代谢活化生成邻苯醌活性代谢物。
- 小鼠实验剂量125-500 mg/kg下未见明显肝毒性,但出现行为异常、低体温及3只死亡。
- 紫堇灵组织分布以肝为主,其次肾、心、脑,可透过血脑屏障。
核心结论
- 紫堇灵经CYP3A4、CYP2C19、CYP2C9和CYP2D6生物活化生成邻苯醌活性代谢物,实验剂量下无明显肝毒性但存在其他毒性表现。
研究设计与样本
- 采用高分辨质谱和三重四极杆质谱研究紫堇灵代谢,体外用大鼠和人肝微粒体加NADPH和谷胱甘肽,体内用小鼠。
- 使用人重组CYP450酶和化学抑制剂法鉴定参与生物活化的CYP同工酶。
- 小鼠实验剂量为125-500 mg/kg,评估肝毒性并观察行为、体温和死亡情况。
- 进行小鼠组织分布研究以确定主要靶器官。
主要发现
- 体外发现3种代谢物(M1-M3)和4种谷胱甘肽结合物(M4-M7)。
- 小鼠体内除M1-M7外还捕获4种半胱氨酸结合物(M8-M11)。
- CYP3A4、CYP2C19、CYP2C9和CYP2D6主要参与紫堇灵生物活化。
- 实验剂量125-500 mg/kg下紫堇灵无明显肝毒性,不诱导急性肝损伤,但小鼠出现行为异常和低体温,3只死亡。
- 组织分布显示主要靶器官为肝,其次肾、心、脑,且可透过血脑屏障,脑内浓度相对较高。
临床怎么用
- 临床使用含紫堇灵的中药时需关注其代谢活化及潜在肝外毒性,尤其对中枢神经系统的影响。
- 注意CYP3A4、CYP2C19、CYP2C9和CYP2D6介导的药物相互作用可能影响紫堇灵代谢。
- 虽然实验剂量下未见明显肝损伤,但行为异常和死亡提示需进一步评估安全性。
局限性
- 研究仅在小鼠中进行肝毒性评价,样本量和统计效力未报告。
- 毒性机制及与代谢活化的直接关联尚未完全阐明。
- 实验剂量范围有限,未涵盖更低或更高剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Corynoline (CRL), an isoquinoline alkaloid, is the major constituent derived from Corydalis bungeana Herba, which is a well-known Chinese herbal medicine widely used in many prescriptions. The purpose of this study was to comprehensively investigate the metabolism and bioactivation of CRL, and identify the CYP450 isoforms involved in reactive ortho-benzoquinone metabolites formation and evaluate its hepatotoxicity in mice. Here, high resolution and triple quadrupole mass spectrometry were used for studying the metabolism of CRL. Three metabolites (M1-M3) and four glutathione conjugates (M4-M7) of CRL ortho-benzoquinone reactive metabolite were found in vitro using rat and human liver microsomes supplemented with NADPH and glutathione. Four cysteine conjugates (M8-M11) were trapped in mice besides M1-M7. Using human recombinant CYP450 enzymes and chemical inhibitor method, we found that CYP3A4, CYP2C19, CYP2C9, and CYP2D6 were mainly involved in the bioactivation of CRL. Furthermore, CRL had no obvious hepatotoxicity and did not induce acute liver injuries in the experimental dosage (125-500 mg/kg) used in this study. However, phenomena of abnormal behaviors and low body temperature appeared in mice after drug administration, and three of them were dead. Tissue distribution study of CRL in mice showed that the main target organ of CRL was liver, then kidney, heart, and brain. CRL could traverse the blood-brain barrier, and have relative high concentration in brain. So, we surmise that toxicity effect of CRL on other organs may have occurred, and more attention should be paid on the traditional Chinese medicine contained CRL in clinic.
引用
- Liu R, Zhou F, He H, et al. Metabolism and Bioactivation of Corynoline With Characterization of the Glutathione/Cysteine Conjugate and Evaluation of Its Hepatotoxicity in Mice. Front Pharmacol. 2018. PMID: 30459618. doi:10.3389/fphar.2018.01264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。